PURE Bioscience (OTCMKTS:PURE – Get Free Report)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.06 and traded as high as $0.0698. PURE Bioscience shares last traded at $0.0556, with a volume of 96,288 shares trading hands.
PURE Bioscience Price Performance
The stock has a market capitalization of $7.23 million, a PE ratio of -1.85 and a beta of 0.22. The firm has a 50 day moving average price of $0.07 and a 200-day moving average price of $0.06.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last issued its earnings results on Monday, June 15th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.51 million during the quarter.
About PURE Bioscience
PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.
PURE’s product suite includes concentrate formulations and ready-to-use solutions.
Featured Articles
- Five stocks we like better than PURE Bioscience
- These Stocks Could Win as Wall Street Looks Beyond AI Software
- D.R. Horton Is Defying the Housing Gloom
- Why Flywire and Airbnb Could Be Quiet Winners of a Ceasefire
- Broadcom and OpenAI Unveil Jalapeño: An Early Step to Massive AI Growth Potential
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
